Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

German Spondyloarthritis Inception Cohort (GESPIC)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
German Federal Ministry of Education and Research (BMBF): 2000-2007 and 2010-2014 through ANCYLOSS and ArthrotMark projects
AbbVie
Amgen
Centocor: 2008-2009
Schering-Plough (MSD): 2008-2009
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by (Responsible Party):
J. Sieper, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT01277419
First received: January 14, 2011
Last updated: November 29, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: July 2018 (Final data collection date for primary outcome measure)
Publications: